Utility of Human In Vitro Data in Risk Assessments of Influenza A Virus Using the Ferret Model

Both in vitro and in vivo models are employed for assessing the pandemic potential of novel and emerging influenza A viruses in laboratory settings, but systematic examinations of how well viral titer measurements obtained in vitro align with results from in vivo experimentation are not frequently performed. We show that certain viral titer measurements following infection of a human bronchial epithelial cell line are positively correlated with viral titers in specimens collected from virus-inoculated ferrets and employ mathematical modeling to identify commonalities between viral infection progression between both models. ABSTRACT As influenza A viruses (IAV) continue to cross species barriers and cause human infection, the establishment of risk assessment rubrics has improved pandemic preparedness efforts. In vivo pathogenicity and transmissibility evaluations in the ferret model represent a critical component of this work. As the relative contribution of in vitro experimentation to these rubrics has not been closely examined, we sought to evaluate to what extent viral titer measurements over the course of in vitro infections are predictive or correlates of nasal wash and tissue measurements for IAV infections in vivo. We compiled data from ferrets inoculated with an extensive panel of over 50 human and zoonotic IAV (inclusive of swine-origin and high- and low-pathogenicity avian influenza viruses associated with human infection) under a consistent protocol, with all viruses concurrently tested in a human bronchial epithelial cell line (Calu-3). Viral titers in ferret nasal wash specimens and nasal turbinate tissue correlated positively with peak titer in Calu-3 cells, whereas additional phenotypic and molecular determinants of influenza virus virulence and transmissibility in ferrets varied in their association with in vitro viral titer measurements. Mathematical modeling was used to estimate more generalizable key replication kinetic parameters from raw in vitro viral titers, revealing commonalities between viral infection progression in vivo and in vitro. Meta-analyses inclusive of IAV that display a diverse range of phenotypes in ferrets, interpreted with mathematical modeling of viral kinetic parameters, can provide critical information supporting a more rigorous and appropriate contextualization of in vitro experiments toward pandemic preparedness. IMPORTANCE Both in vitro and in vivo models are employed for assessing the pandemic potential of novel and emerging influenza A viruses in laboratory settings, but systematic examinations of how well viral titer measurements obtained in vitro align with results from in vivo experimentation are not frequently performed. We show that certain viral titer measurements following infection of a human bronchial epithelial cell line are positively correlated with viral titers in specimens collected from virus-inoculated ferrets and employ mathematical modeling to identify commonalities between viral infection progression between both models. These analyses provide a necessary first step in enhanced interpretation and incorporation of in vitro-derived data in risk assessment activities and highlight the utility of employing mathematical modeling approaches to more closely examine features of virus replication not identifiable by experimental studies alone.

[1]  N. Vrana,et al.  Prediction of coating thickness for polyelectrolyte multilayers via machine learning , 2021, Scientific Reports.

[2]  Anice C. Lowen,et al.  Quantitative Approach To Assess Influenza A Virus Fitness and Transmission in Guinea Pigs , 2021, Journal of Virology.

[3]  Amanda P. Smith,et al.  Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample’s infection concentration , 2021, PLoS Comput. Biol..

[4]  C. Davis,et al.  Mammalian pathogenicity and transmissibility of low pathogenic avian influenza H7N1 and H7N3 viruses isolated from North America in 2018 , 2020, Emerging microbes & infections.

[5]  Christian Quirouette,et al.  A mathematical model describing the localization and spread of influenza A virus infection within the human respiratory tract , 2019, PLoS Comput. Biol..

[6]  T. Tumpey,et al.  Mammalian pathogenicity and transmissibility of a reassortant Eurasian avian-like A(H1N1v) influenza virus associated with human infection in China (2015). , 2019, Virology.

[7]  S. Riley,et al.  Cellular reproduction number, generation time and growth rate differ between human- and avian-adapted influenza strains , 2019, 1903.08054.

[8]  T. Tumpey,et al.  Sowing the Seeds of a Pandemic? Mammalian Pathogenicity and Transmissibility of H1 Variant Influenza Viruses from the Swine Reservoir , 2019, Tropical medicine and infectious disease.

[9]  J. Belser Cell culture keeps pace with influenza virus. , 2018, The Lancet. Respiratory medicine.

[10]  H. Clevers,et al.  Tropism, replication competence, and innate immune responses of influenza virus: an analysis of human airway organoids and ex-vivo bronchus cultures. , 2018, The Lancet. Respiratory medicine.

[11]  Wendy S. Barclay,et al.  Host and viral determinants of influenza A virus species specificity , 2018, Nature Reviews Microbiology.

[12]  T. Tumpey,et al.  Risk Assessment of Fifth-Wave H7N9 Influenza A Viruses in Mammalian Models , 2018, Journal of Virology.

[13]  T. Tumpey,et al.  Comparative In Vitro and In Vivo Analysis of H1N1 and H1N2 Variant Influenza Viruses Isolated from Humans between 2011 and 2016 , 2018, Journal of Virology.

[14]  Huachen Zhu,et al.  Ferrets as Models for Influenza Virus Transmission Studies and Pandemic Risk Assessments , 2018, Emerging infectious diseases.

[15]  C. Davis,et al.  Pathogenesis and Transmission of Genetically Diverse Swine-Origin H3N2 Variant Influenza A Viruses from Multiple Lineages Isolated in the United States, 2011–2016 , 2018, Journal of Virology.

[16]  Andreas Handel,et al.  Exploring the impact of inoculum dose on host immunity and morbidity to inform model-based vaccine design , 2018, bioRxiv.

[17]  C. Davis,et al.  Antigenically Diverse Swine Origin H1N1 Variant Influenza Viruses Exhibit Differential Ferret Pathogenesis and Transmission Phenotypes , 2018, Journal of Virology.

[18]  T. Tumpey,et al.  Mammalian Pathogenesis and Transmission of Avian Influenza A(H7N9) Viruses, Tennessee, USA, 2017 , 2018, Emerging infectious diseases.

[19]  C. Davis,et al.  Assessment of Molecular, Antigenic, and Pathological Features of Canine Influenza A(H3N2) Viruses That Emerged in the United States , 2017, The Journal of infectious diseases.

[20]  T. Tumpey,et al.  Pathogenesis, Transmissibility, and Tropism of a Highly Pathogenic Avian Influenza A(H7N7) Virus Associated With Human Conjunctivitis in Italy, 2013 , 2017, The Journal of infectious diseases.

[21]  T. Uyeki,et al.  Novel influenza A viruses and pandemic threats , 2017, The Lancet.

[22]  T. Tumpey,et al.  A Novel A(H7N2) Influenza Virus Isolated from a Veterinarian Caring for Cats in a New York City Animal Shelter Causes Mild Disease and Transmits Poorly in the Ferret Model , 2017, Journal of Virology.

[23]  C. Davis,et al.  Enhanced virulence of clade 2.3.2.1 highly pathogenic avian influenza A H5N1 viruses in ferrets. , 2017, Virology.

[24]  T. Tumpey,et al.  Pathogenesis and Transmission Assessments of Two H7N8 Influenza A Viruses Recently Isolated from Turkey Farms in Indiana Using Mouse and Ferret Models , 2016, Journal of Virology.

[25]  T. Tumpey,et al.  Complexities in Ferret Influenza Virus Pathogenesis and Transmission Models , 2016, Microbiology and Molecular Reviews.

[26]  C. Beauchemin,et al.  Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses , 2016, Scientific Reports.

[27]  T. Bestebroer,et al.  Multiple Natural Substitutions in Avian Influenza A Virus PB2 Facilitate Efficient Replication in Human Cells , 2016, Journal of Virology.

[28]  Andreas Handel,et al.  Within-Host Models of High and Low Pathogenic Influenza Virus Infections: The Role of Macrophages , 2016, PloS one.

[29]  T. Tumpey,et al.  Mammalian Pathogenesis and Transmission of H7N9 Influenza Viruses from Three Waves, 2013-2015 , 2016, Journal of Virology.

[30]  Lloyd H. Michael,et al.  The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.

[31]  Michael G. Buhnerkempe,et al.  Mapping influenza transmission in the ferret model to transmission in humans , 2015, eLife.

[32]  T. Tumpey,et al.  Pathogenesis and Transmission of Novel Highly Pathogenic Avian Influenza H5N2 and H5N8 Viruses in Ferrets and Mice , 2015, Journal of Virology.

[33]  C. Beauchemin,et al.  Impact of the H275Y and I223V Mutations in the Neuraminidase of the 2009 Pandemic Influenza Virus In Vitro and Evaluating Experimental Reproducibility , 2015, PloS one.

[34]  W. Barclay,et al.  Viral determinants of influenza A virus host range. , 2014, The Journal of general virology.

[35]  N. Cox,et al.  Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT). , 2014, Current topics in microbiology and immunology.

[36]  T. Tumpey,et al.  Impact of Prior Seasonal H3N2 Influenza Vaccination or Infection on Protection and Transmission of Emerging Variants of Influenza A(H3N2)v Virus in Ferrets , 2013, Journal of Virology.

[37]  Y. Guan,et al.  Tropism and innate host responses of a novel avian influenza A H7N9 virus: an analysis of ex-vivo and in-vitro cultures of the human respiratory tract , 2013, The Lancet Respiratory Medicine.

[38]  T. Tumpey,et al.  Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice , 2013, Nature.

[39]  A. Klimov,et al.  Influenza: Propagation, Quantification, and Storage , 2013, Current protocols in microbiology.

[40]  C. Davis,et al.  Pathogenesis, Transmissibility, and Ocular Tropism of a Highly Pathogenic Avian Influenza A (H7N3) Virus Associated with Human Conjunctivitis , 2013, Journal of Virology.

[41]  J. P. Long,et al.  Clinical Profiles Associated with Influenza Disease in the Ferret Model , 2013, PloS one.

[42]  Guy Boivin,et al.  The H275Y Neuraminidase Mutation of the Pandemic A/H1N1 Influenza Virus Lengthens the Eclipse Phase and Reduces Viral Output of Infected Cells, Potentially Compromising Fitness in Ferrets , 2012, Journal of Virology.

[43]  N. Cox,et al.  Pathogenesis and transmission of swine origin A(H3N2)v influenza viruses in ferrets , 2012, Proceedings of the National Academy of Sciences.

[44]  T. Tumpey,et al.  Local innate immune responses and influenza virus transmission and virulence in ferrets. , 2012, The Journal of infectious diseases.

[45]  T. Tumpey,et al.  Efficacy of seasonal live attenuated influenza vaccine against virus replication and transmission of a pandemic 2009 H1N1 virus in ferrets. , 2011, Vaccine.

[46]  Andreas Handel,et al.  A review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges ahead , 2011, BMC public health.

[47]  T. Tumpey,et al.  Pathogenesis and Transmission of Triple-Reassortant Swine H1N1 Influenza Viruses Isolated before the 2009 H1N1 Pandemic , 2010, Journal of Virology.

[48]  T. Tumpey,et al.  The 2009 Pandemic H1N1 and Triple-Reassortant Swine H1N1 Influenza Viruses Replicate Efficiently but Elicit an Attenuated Inflammatory Response in Polarized Human Bronchial Epithelial Cells , 2010, Journal of Virology.

[49]  P. Massin,et al.  Temperature sensitivity on growth and/or replication of H1N1, H1N2 and H3N2 influenza A viruses isolated from pigs and birds in mammalian cells. , 2010, Veterinary microbiology.

[50]  Rahul Raman,et al.  Transmission and Pathogenesis of Swine-Origin 2009 A(H1N1) Influenza Viruses in Ferrets and Mice , 2009, Science.

[51]  K. Subbarao,et al.  Avian Influenza Virus Glycoproteins Restrict Virus Replication and Spread through Human Airway Epithelium at Temperatures of the Proximal Airways , 2009, PLoS pathogens.

[52]  John Steel,et al.  Transmission of Influenza Virus in a Mammalian Host Is Increased by PB2 Amino Acids 627K or 627E/701N , 2009, PLoS pathogens.

[53]  T. Tumpey,et al.  Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibility , 2008, Proceedings of the National Academy of Sciences.

[54]  T. Tumpey,et al.  Highly Pathogenic Avian Influenza H5N1 Viruses Elicit an Attenuated Type I Interferon Response in Polarized Human Bronchial Epithelial Cells , 2007, Journal of Virology.

[55]  T. Tumpey,et al.  Pathogenesis of Avian Influenza (H7) Virus Infection in Mice and Ferrets: Enhanced Virulence of Eurasian H7N7 Viruses Isolated from Humans , 2007, Journal of Virology.

[56]  J. Katz,et al.  Influenza: Propagation, Quantification, and Storage , 2006, Current protocols in microbiology.

[57]  N. Cox,et al.  Lack of transmission of H5N1 avian–human reassortant influenza viruses in a ferret model , 2006, Proceedings of the National Academy of Sciences.

[58]  N. Cox,et al.  Avian Influenza (H5N1) Viruses Isolated from Humans in Asia in 2004 Exhibit Increased Virulence in Mammals , 2005, Journal of Virology.

[59]  G. Rettinger,et al.  Nasal mucosal temperature during respiration. , 2002, Clinical otolaryngology and allied sciences.

[60]  Thomas Rowe,et al.  Pathogenesis of Avian Influenza A (H5N1) Viruses in Ferrets , 2002, Journal of Virology.

[61]  T. Keck,et al.  Temperature Profile in the Nasal Cavity , 2000, The Laryngoscope.

[62]  B. Murphy,et al.  A single amino acid in the PB2 gene of influenza A virus is a determinant of host range , 1993, Journal of virology.

[63]  W. Russell,et al.  The Principles of Humane Experimental Technique , 1960 .